Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Madrigal Pharmaceuticals Inc
MDGL | US
512.39
USD-6.35
-1.22%
MDGL | US
Loading StockChartView...
About Madrigal Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
512.39
Open
518.00
High
522.18
Low
500.97
Madrigal Pharmaceuticals Inc. a clinical-stage biopharmaceutical company focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom a liver-directed selective thyroid hormone receptor beta agonist which is in Phase III clinical trials for treating NASH. The company is also developing MGL-3745 a backup compound to resmetirom. The company is headquartered in West Conshohocken Pennsylvania.
View LessMDGL | US
Risk
51.7
Sharpe
1.36
Luna's Score
57/100
Recommendation
Hold
Luna says (MDGL | US)
What's Working
Largecap (10B - 200B USD)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
Low negative Beta, possible Low Liquidity (< -0.4)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
18.0%1 month
51.7%3 months
44.9%6 months
46.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
5.33
Debt to equity
0.14
Debt to assets
0.11
Ent. to EBITDA
-8.32
Ent. to rev.
247.99
PEG
-
Other Fundamentals
EBITDA
-529.57M
MarketCap
11.13B
MarketCap(USD)
11.13B
Div. yield
-
Op. margin
-1.11K
Erngs. growth
-
Rev. growth
-
Ret. on equity
-106.27
Short ratio
15.51
Short perc.
25.58
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
38.20
Range1M
123.70
Range3M
155.99
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.57
Price X volume
102.63M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -8.32 | 0.53 | Cheaper |
| Ent. to Revenue | 247.99 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 5.33 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 44.86 | 72.80 | Lower Risk |
| Debt to Equity | 0.14 | -1.23 | Expensive |
| Debt to Assets | 0.11 | 0.25 | Cheaper |
| Market Cap | 11.13B | 3.66B | Market Leader |
